Protocol Deviations in Clinical Trials of New Drug Application

ZHU Sai-nan,YU Yong-pei,YAN Xiao-yan,YAO Chen

2012-01-01

Abstract:Objective: To reveal the status of protocol deviations in clinical trials of new drug application,and to give reference information to improve the quality of clinical trials.Methods: Thirty six clinical trials of phase II and phase III were collected and the reasons of deviation from design were coded.Results: The deviations were little associated with the basic information of these trials.The most important types were lost(27.73%),not accord with inclusion and exclusion criteria(14.43%),the combined medicine use that influence the efficacy of drugs(14.05%),poor compliance(11.42%),withdrawal because of adverse event(10.92%),and so on.The most important types of deviation affecting population dividing into FAS and PPS were loss of follow-up,and incorrect inclusion and exclusion criteria.For SS,it was lost to follow-up,and the SS set was lost also.Conclusion: Most of the reasons that lead to the plan deviations is associated with the implementation quality of the trials,only a little are related to the characteristics of the drug itself.It is very important to take measures to improve the quality of the study by the sponsors and monitors in their own aspects.